Clinical Trials Directory

Trials / Completed

CompletedNCT01116115

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005)

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters, Anthropometric Parameters and Stool Characteristics in Term Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Enzymotec · Industry
Sex
All
Age
7 Days
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters in term formula fed infants.

Detailed description

InFatTM is an advanced basic-fat ingredient, which mimics the fat composition and properties of human milk fat and enabling optimal intake of the essential calcium and energy (in the form of fatty acids) and easy digestion. These benefits are the result of a unique fatty acid composition on the glycerol backbone, which ensures high level of palmitic acid at the middle (sn-2) position. The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters, anthropometric parameters and stool characteristics in formula fed term infants.

Conditions

Interventions

TypeNameDescription
OTHERInFat™ based infant formulaHigh sn-2 palmitic acid oil based infant formula
OTHERStandard vegetable oil based infant formulaStandard vegetable oil based infant formula

Timeline

Start date
2010-04-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2010-05-04
Last updated
2011-05-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01116115. Inclusion in this directory is not an endorsement.